Ophthalmology and Optometry articles for China

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 102

Article ‘Count’ for Ophthalmology and Optometry.

Journal Count Share
7 7.00
Maternal-Derived Polystyrene Nanoplastics Impair Early Retinal Development in Zebrafish (Danio rerio) 1.00
Iron Homeostasis Restoration via Triple-Pool-Targeted Nanotherapy for Enhanced Amelioration of Age-Related Macular Degeneration 1.00
Self-Adaptive Hydrogen Nano-Delivery System in Glaucoma Management: Synergistic Antioxidation and Anti-inflammation Therapeutic Strategy 1.00
Dual-Pronged Strategy on Autoimmune Uveitis by Topical Application of Bioactive Carbon Dots from Natural Herbs 1.00
Enzyme-Mimetic Hydrogel Balancing Antibacterial Activity and Cytoprotection for Corneal Regeneration in Bacterial Keratitis 1.00
Highly Efficient Intrastromal Dual-Drug Delivery by a Dissolving Bilayer Microneedle for Synergistic Therapy against Corneal Neovascularization 1.00
Human Corneal Lenticules Decorated with Mesenchymal-Stem-Cells-Encapsulated Microneedles for Cornea Stroma Regeneration 1.00
9 9.00
A metal-organic framework-based trilayer biomimetic coating on lacrimal stents for dual-drug therapy to prevent restenosis 1.00
Lightweight, elastic and bioactive scaffolds with enhanced vascularization and anti-inflammation for post-enucleation orbital reconstruction 1.00
Limbal Organoids and Bioengineering Sheets Based on Niche Microphysiological Systems and Bioprinting for Corneal Injury Repair in Rabbits 1.00
Matrix Stiffness Promotes Corneal Fibrosis through the YAP/TAZ–β-catenin Mechanotransduction Pathway: Proteomic and Functional Validation 1.00
Tear Glucose-Responsive and Photo-activated Antibacterial Hydrogel Bandage with Bio-heterojunction for the Treatment of Drug-Resistant Bacterial Corneal Infection 1.00
A natural corneal extracellular matrix-inspired dual-crosslinked hydrogel bioadhesive for emergency corneal trauma repair 1.00
Fluorinated ROS-responsive polycation enables noninvasive siRNA Delivery for the treatment of corneal neovascularization 1.00
Hybrid cell-membrane-coated biomimetic nanoparticles for targeted noninvasive intervention in early diabetic retinopathy 1.00
RGD peptide hydrogel downregulates mechanosignal YAP to inhibit postoperative scarring 1.00
14 13.63
In Situ Refractive Index Buffering Strategy for Transparent LiTaO3 Glass Composites With High Crystallinity 0.63
Biomimetic Hydrogel Microneedle Patch for Treating Corneal Injury‐Associated Bacterial Keratitis 1.00
Localized Silodosin Delivery via a Separable Microneedle Patch Promoting ROS Scavenging and Modulating NA–Adra1a–Ucp2 Signaling in Dry Eye Disease 1.00
Sustained Ocular Antioxidant Therapy With Thiolated Catalase for Intervention of Corneal Injuries and Atopic Conjunctivitis 1.00
Size-Evolving Protein Drug Nanoparticles: A Promising Non-Invasive Strategy for Retinal Neovascularization by Overcoming Multiple Ocular Barriers 1.00
Biomimetic Non‐Conjugated Segment‐Doped Conjugated Polymer Nanoplatform for Bright NIR‐II Imaging‐Guided Phototherapy of Choroidal Melanoma 1.00
High-Responsive Photochromic High-Entropy Materials for Image-Matrix Encrypted Storage 1.00
Chlorella-Based “Carrier-as-Therapeutic” Platform: Dual-Pathology Therapy and Translational Efficacy for Meibomian Gland Dysfunction 1.00
Bioactive P(VDF‐TrFE) Bandage Contact Lenses Enhance Corneal Wound Healing Through Microelectric Field Stimulation 1.00
Framework Nucleic Acids Nanoplatform Regulating Cellular Stemness and Oxidative Microenvironment for Synergistic Treatment of Ocular Surface Disorders 1.00
Electrostatically Engineered Polyoxometalate Contact Lenses for Integrated Shielding of UV Radiation and Ozone‐Induced Ocular Stress 1.00
FeDSNP-Pa Nanoassemblies: A Triple-Action Therapeutic Strategy Targeting Oxidative Stress, Inflammation, and Pyroptosis for Retinal Ganglion Cell Protection in Glaucoma 1.00
A Customized Janus Hydrogel with Both Anti‐Fibrosis and Anti‐Infection Properties for Suture‐Free and Care‐Free Corneal Injury Repair 1.00
Platelet Membrane‐Camouflaged ROS‐Responsive Nanoplatform for Targeted Delivery and Sustained Release of Verteporfin to Modulate Hippo Signaling Pathway in Glaucoma Therapy 1.00
4 3.84
Disrupting the Oxidative Stress–Inflammation–Corneal Neovascularization Cycle with Ultrasmall Nanoparticles 0.95
Point-Excitation Wide-Field Upconversion Imaging via a Holographic Polymer Waveguide 1.00
Trojan Horse‐Inspired Biomimetic Lipoprotein Nanocarrier for Noninvasive Anti‐VEGF Therapy of Ocular Fundus Neovascularization 1.00
Iron-Chelating and ROS-Scavenging Polymers with Thioketal and Thioether Bonds Delivering Ferroptosis Inhibitor Lip-1 Provide a Triple Therapeutic Strategy for Retina Ganglion Cells in Acute Glaucoma 0.89
7 6.11
Evaluating the Accuracy, Safety, and Equity of Multimodal Large Language Models for Real-World Ocular Surface Disease Diagnosis 1.00
Loss of Triggering Receptor Expressed on Myeloid Cells 2 Impairs Microglial Function and Exacerbates Retinal Neurodegeneration in Glaucoma 1.00
Growth Differentiation Factor 11 Promotes Corneal Endothelial Injury Repair by Activating the SOX9–β-Catenin Signaling Pathway 1.00
Single-Cell Network Analysis Reveals Cell-Type-Specific Pathology Following Retinal Detachment 1.00
DNMT3A-dependent suppression of HIF-1α alleviates myopia by reducing scleral ferroptosis and fibroblast extracellular matrix remodeling 1.00
Dehydroepiandrosterone Prevents Collagen Loss by Regulating HIF-1α Expression and Mitophagy in Hypoxic Human Scleral Fibroblasts 1.00
DNA Methylation Dynamics in a Mouse Model of Retinitis Pigmentosa 0.11
3 3.00
Nanostructured High-Entropy Yolk–Shell Oxides Platform for Efficient Metabolic Profiling of Diabetic Retinopathy 1.00
Multicenter Validation of Metabolomic Fingerprints for Accurate Diagnosis, Subtyping, and Severity Stratification of Glaucoma 1.00
Transcriptome Analysis of Tear-Derived Extracellular Vesicles as Biomarkers for Diabetic Retinopathy 1.00
1 1.00
Longitudinal evaluation of a precise ciliary body radiofrequency ablation for glaucoma treatment using multimodal imaging 1.00
1 1.00
Comparative Real‐World Effectiveness of Immunomodulatory Therapies for Prevention of Uveitis Relapse in Behçet's Disease 1.00
1 1.00
High-performance X-ray imaging enabled by in situ recrystallized antimony(iii)-based halide glass-ceramics 1.00
1 0.90
Perfluorooctane sulfonate (PFOS) induces Caspase-8-mediated pyroptosis via GSDMD and GSDME to drive retinal disease: Evidence from epidemiological and experimental studies 0.90
3 3.00
Placental DNA Methylation as a Mediator in the Association Between Maternal Prenatal Bisphenol Analogue Exposure and Myopia in Children: A Long-term Prospective Cohort Study 1.00
Outdoor artificial light at night exposure and risk of myopia: A cross-sectional and prospective cohort study among Hong Kong children 1.00
Dual associations of post-sleep and pre-wake light-at-night (LAN) exposure with myopia in children and adolescents 1.00
2 2.00
The Liquid Crystal Monomer 3cH2B Affects the Visual System via Neural-Cell-Specific Retinoic Acid Disruption in the Optic Tectum 1.00
Microglia-Mediated Pathological Retinal Angiogenesis Leading to Visual Impairment in Mice Exposed to Perfluorooctanoic Acid 1.00
1 1.00
Nonlinear Viscoelastic Model-based Deformation Optimization for Robotic Micropuncture in Retinal Vein Cannulation 1.00
1 1.00
Initiation-Confined Holographic Photopolymerization under Visible Light 1.00
1 1.00
Effect of Intensive Blood Pressure Lowering Treatment on Retinal Microvasculature Secondary Analysis From ESPRIT 1.00
2 2.00
Engineering of a Mantis-Forelimb-Inspired Bioabsorbable Lens-like Ocular Therapeutic (BLOT) Device for Effective Bacterial Keratitis Treatment 1.00
Biomimetic Metal–Organic Antioxidant Eye Drops for Corneal Neovascularization: Visible-Light-Triggered CO Release for Microenvironment Regulation 1.00
15 11.54
FRZB-induced anti-angiogenic effect via Caveolin-1-mediated TGFβ signalling 0.08
KIF11 prevents retinal endothelial ferroptosis in familial exudative vitreoretinopathy by inhibiting phosphorylation-driven PRDX1 phase separation 1.00
Self-polymerized polyphenol-based platform for the management of dry eye pathogenesis 1.00
Permeable nanoreactor eye drop for enzymatic cascade-mediated treatment for acute retinal injury model mimicking geographic atrophy 1.00
Routine blood tests and machine learning identify complications in high myopia 1.00
Decreased scleral Wnt5ahi fibroblasts exacerbate myopia progression by disrupting extracellular matrix homeostasis in mice 1.00
Endothelial RAB5IF is required for pathological and developmental retinal angiogenesis 1.00
Artificial intelligence-driven metabolomics of retinal nerve fibre layer to profile risks of mortality and cardiometabolic diseases 0.55
Chemical reprogramming of fibroblasts into retinal pigment epithelium cells for vision restoration 1.00
A mass spectrometry-based strategy allows signature metabolite identification in tear fluid from people with diabetic cataracts 1.00
GWAS for primary angle-closure glaucoma identifies loci related to ocular biometry and morphology 0.05
iPSC-derived ITGA6-positive cells restore aqueous humor outflow in glaucoma eyes 0.88
Propagation-adaptive 4K computer-generated holography using physics-constrained spatial and Fourier neural operator 1.00
Functionally deficient UBOX5 variants and primary angle-closure glaucoma 0.04
A gatekeeper sympathetic control of lacrimal tear secretion and dry eye onset through the NA-Adra1a-Ucp2 pathway 0.94
1 0.18
Multi-ancestry genome-wide association analyses of refractive error augment genetic discovery and polygenic prediction 0.18
2 1.28
AI framework for multidisease detection via retinal imaging 0.73
An eyecare foundation model for clinical assistance: a randomized controlled trial 0.54
8 3.49
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension Trial 0.06
Incidence and associated factors of myopic maculopathy progression after posterior scleral contraction in high myopia 1.00
Efficacy and safety of Syk/VEGFR-2 Dual-target Kinase Inhibitor (OT202) in Dry Eye: A Randomized, Vehicle-controlled, Phase 2 Trial 1.00
Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR Trial 0.10
The Prevalence of Diabetic Retinopathy in American Indians/Alaska Natives and non-Indigenous Americans: A Systematic Review and Meta-Analysis 0.03
S.T.O.P kit for Myopia Control: Stage 1 results from a randomized controlled clinical trial in Chinese children. 0.27
Baseline OCT Biomarkers Predicting Visual Outcomes in Neovascular Age-Related Macular Degeneration: A Meta-Analysis 0.03
Establishment of Myopia Occurrence Prediction Model in Non-myopic Children Using Cycloplegic Refraction and Prior Axial Length Change 1.00
1 1.00
Analysis of retinal markers and incident amyotrophic lateral sclerosis: An optical coherence tomography-based cohort study 1.00
5 4.02
DAPL1 restrains RPE PANoptosis in experimental AMD by inhibiting GRP75-mediated mitochondria-associated endoplasmic reticulum membranes 0.92
Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy 0.30
Sorting nexin 3 promotes ischemic retinopathy through RIP1- and RIP3-mediated myeloid cell necroptosis and mitochondrial fission 0.94
Single-cell transcriptome combined with genetic tracing reveals a roadmap of fibrosis formation during proliferative vitreoretinopathy 0.94
Feedback regulation between histone lactylation and ALKBH3-mediated glycolysis regulates age-related macular degeneration pathology 0.92
10 8.93
TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa 1.00
Synergistic antioxidant and gene supplementation for high-efficacy retinitis pigmentosa therapy 1.00
Functional targeting of PTTG1 in pericytes restores vascular integrity in diabetic retina 1.00
Apolipoprotein E drives microglia activation in the development of autoimmune uveitis through up-regulation of peptidyl prolyl isomerase F 1.00
MSC-encapsulated porous microparticle eye drops for autoimmune dry eye disease treatment in NOD mice 1.00
Nanozyme eye drops for retinal barrier penetration and vasculopathy repair 1.00
Temporal biphasic regulation of photoreceptor degeneration by microglial TREM2: A metabolic-immune nexus in retinitis pigmentosa 1.00
Thermoresponsive antioxidant metal-free carbon nanodot hydrogel: An effective therapeutic approach for ocular surface disease 0.86
Parallel writing of 5D optical data via shaped voxels 1.00
Metabolic regulation of visual acuity 0.07
1 0.39
Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens 0.39
1 0.11
Effective cataract surgical coverage in adults aged 50 years and older: empirical estimates from population-based surveys in 68 countries and modelled estimates for 2000–30 0.11

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.